search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


11 resulaten gevonden voor Acute Lymphoblastic Leukemia in trials

DexaDagen-2 study
- TRIAL ID
NTR6695
- ACRONYM
Bortezomib for children with acute lymphoblastic leukemia (ALL) without other treatment options.
- TRIAL ID
NTR1881
- ACRONYMBortezomib in relapsed ALL
Development and introduction of a pediatric liquid formulation of 6-mercaptopurine for treatment of leukemia.
- TRIAL ID
NTR1633
- ACRONYM6MP formulation
A phase II study to assess engraftment and engraftment kinetics after double cord blood transplantation with a reduced-intensity conditioning regimen in patients eligible for allogeneic stem cell transplantation lacking a matched unrelated donor.
- TRIAL ID
NTR1573
- ACRONYMEngraftment after double cord blood transplantation.
Molecular determinants of bone mineral density in children with acute lymphoblastic leukemia and the role of intervention by physical activities and calcium and vitamin D supplement as a preventive strategy.
- TRIAL ID
NTR477
- ACRONYMintervention study on BMD in ALL
Protocol for treatment and research of acute lymphoblastic leukaemia of childhood of the Dutch Childhood Oncology Group (SNWLK/DCOG ALL-9).
- TRIAL ID
NTR460
- ACRONYMSNWLK-ALL-9
Comparative pharmacokinetics, pharmacodynamics, efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia (ALL).
- TRIAL ID
NTR402
- ACRONYMN/A
Protection against chemotherapy induced damage in the digestive tract in childhood cancer patients.
- TRIAL ID
NTR401
- ACRONYMN/A
The effect of physiotherapy on development, extent and duration of motor problems in children with acute lymphoblastic leukaemia.
- TRIAL ID
NTR251
- ACRONYMN/A
Early intensification by (un)related allogeneic or autologous stem cell transplantation in adult acute lymphoblastic leukemia. A phase II study.
- TRIAL ID
NTR228
- ACRONYMHOVON 37 ALL
Interfant 99.
- TRIAL ID
NTR182
- ACRONYMInterfant 99